Armistice Capital, LLC Cytokinetics Inc Call Options Transaction History

Armistice Capital, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2025 May 15, 2025	BUY	$40.19 - $51.12 $84 Million - $107 Million	2,090,000 Added 342.62%	2,700,000 $109 Million
Q4 2024 Feb 14, 2025	SELL	$46.36 - $58.62 $73.7 Million - $93.2 Million	-1,590,000 Reduced 72.27%	610,000 $28.7 Million
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $61.5 Million - $72.2 Million	1,200,000 Added 120.0%	2,200,000 $116 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $14.4 Million - $22.5 Million	300,000 Added 42.86%	1,000,000 $54.2 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $44.6 Million - $75.6 Million	700,000 New	700,000 $49.1 Million

402

127M

3.66M

900K

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.51B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.